Literature DB >> 34905584

Correction: Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI.

Katherine A Ruppert, Karthik S Prabhakara, Naama E Toledano-Furman, Sanjna Udtha, Austin Q Arceneaux, Hyeonggeun Park, An Dao, Charles S Cox, Scott D Olson.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0233263.].

Entities:  

Year:  2021        PMID: 34905584      PMCID: PMC8670670          DOI: 10.1371/journal.pone.0261599

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Fig 5 is incorrect. The authors have provided a corrected version here.
Fig 5

Representative localization of neuroinflammation and neurogenesis.

Thin sections from ipsilateral and contralateral hemispheres were immunostained at Day 32. Presented here are portions of the thalamus and hippocampus, specifically the subgranular zone (SGZ). A. Antibodies for NeuN and Doublecortin (DCX) were used to stain for neurogenesis, B, C. IBA-1 for microglial activation and D, E. GFAP for reactive astrocytes. Images are representative of sham, CCI + vehicle, CCI + HB-adMSCs 3d and CCI + HB-adMSCs 14d, at 20x magnification with a 10x inset showing a larger field. Scale bars indicate 200 μm.

Representative localization of neuroinflammation and neurogenesis.

Thin sections from ipsilateral and contralateral hemispheres were immunostained at Day 32. Presented here are portions of the thalamus and hippocampus, specifically the subgranular zone (SGZ). A. Antibodies for NeuN and Doublecortin (DCX) were used to stain for neurogenesis, B, C. IBA-1 for microglial activation and D, E. GFAP for reactive astrocytes. Images are representative of sham, CCI + vehicle, CCI + HB-adMSCs 3d and CCI + HB-adMSCs 14d, at 20x magnification with a 10x inset showing a larger field. Scale bars indicate 200 μm.
  1 in total

1.  Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI.

Authors:  Katherine A Ruppert; Karthik S Prabhakara; Naama E Toledano-Furman; Sanjna Udtha; Austin Q Arceneaux; Hyeonggeun Park; An Dao; Charles S Cox; Scott D Olson
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.